HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Polanc Selected Research

N(1)- phenyl- N(2)- (2- pyridinylmethyl)diazenedicarboxamide

1/2006Structurally similar diazenes exhibit significantly different biological activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Polanc Research Topics

Disease

4Carcinoma (Carcinomatosis)
03/2006 - 01/2000
2Neoplasms (Cancer)
03/2006 - 01/2000
2Glioblastoma (Glioblastoma Multiforme)
01/2006 - 04/2003
2Adenocarcinoma
01/2006 - 04/2003
1Necrosis
01/2006

Drug/Important Bio-Agent (IBA)

3diazeneIBA
03/2006 - 01/2000
2Pharmaceutical PreparationsIBA
04/2003 - 01/2000
1N- phenyl- 2- (2- pyridinyl)diazenecarboxamideIBA
03/2006
1Glutathione (Reduced Glutathione)IBA
03/2006
1Cisplatin (Platino)FDA LinkGeneric
03/2006
1N(1)- phenyl- N(2)- (2- pyridinylmethyl)diazenedicarboxamideIBA
01/2006
1Caspase 3 (Caspase-3)IBA
01/2006

Therapy/Procedure

1Therapeutics
03/2006